Current Drug Targets

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Trastuzumab-Induced Cardiotoxicity: Is it a Personalized Risk?

Volume:15   Issue:13
Pp: 1200-1204
Gerard A. Milano, Emilie Serres, Jean-Marc Ferrero and Joseph Ciccolini
DOI: 10.2174/1389450115666141114151911

Order Reprints Order Eprints

Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials

Volume:15   Issue:13
Pp: 1205-1214
Mickael Bonnan, Sylvie Ferrari, Eric Bertandeau, Stephanie Demasles, Elsa Krim, Marie Miquel and Bruno Barroso
DOI: 10.2174/1389450115666141029234644

Order Reprints Order Eprints

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

Volume:15   Issue:13
Pp: 1225-1230
Riccardo Giampieri, Giuseppe Aprile, Michela Del Prete, Luca Faloppi, Maristella Bianconi, Marta Bonotto, Giampiero Fasola, Stefano Cascinu and Mario Scartozzi
DOI: 10.2174/1389450115666141109212801

Order Reprints Order Eprints

Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases

Volume:15   Issue:13
Pp: 1231-1246
Albino Carrizzo, Maurizio Forte, Maria Lembo, Luigi Formisano, Annibale A. Puca and Carmine Vecchione
DOI: 10.2174/1389450115666141027110156

Order Reprints Order Eprints